bioAffinity Technologies, Inc. (BIAF) vs DermTech, Inc. (DMTKQ)
- bioAffinity Technologies, Inc. BIAF 3.73 −5.81%
- DermTech, Inc. DMTKQ 0.00 NaN
bioAffinity Technologies, Inc. and DermTech, Inc. are both Diagnostics & Research companies. bioAffinity Technologies, Inc. is the larger, with a market value of $5.1M against $3.3M — 1.5× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −23.2%. bioAffinity Technologies, Inc. has the higher net margin (−257.3% vs −572.2%) and the higher return on invested capital (−408.7% vs −5,493.5%). Across the 16 metrics below, DermTech, Inc. leads on 9 and bioAffinity Technologies, Inc. on 7.
Valuation
Profitability
| Metric | BIAF | DMTKQ | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 34.61% | 8.51% | 50.89% |
| Operating margin | (209.82%) | (588.62%) | (8.57%) |
| Net margin | (257.33%) | (572.19%) | (6.37%) |
| Free cash flow margin | (195.90%) | (460.10%) | 0.00% |
| Return on equity | (1,860.15%) | (121.75%) | (2.92%) |
| Return on assets | (245.51%) | (64.00%) | (6.71%) |
| Return on invested capital | (408.67%) | (5,493.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack